Lincoln Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|
| Revenue | 161.30 | 155.52 | 171.19 |
| Operating Expense | 141.46 | 122.89 | 132.83 |
| Net Profit | 11.58 | 20.77 | 26.33 |
| Net Profit Margin | 7.18 | 13.36 | 15.38 |
| Earning Per Share | 5.78 | 10.37 | 13.15 |
| EBIDTA | 21.83 | 32.77 | 35.02 |
| Effective Tax Rate | 33.52 | 24.67 | 13.35 |
| Particulars | Mar 2025 |
|---|---|
| Revenue | 161.30 |
| Operating Expense | 141.46 |
| Net Profit | 11.58 |
| Net Profit Margin | 7.18 |
| Earning Per Share | 5.78 |
| EBIDTA | 21.83 |
| Effective Tax Rate | 33.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 580.55 | 510.31 | 472.08 |
| Operating Expenses Annual | 480.64 | 421.14 | 376.61 |
| Operating Profit Annual | 134.33 | 111.65 | 105.47 |
| Interest Annual | 1.46 | 2.03 | 1.45 |
| Depreciation | 10.52 | 9.05 | 7.95 |
| Net Profit Annual | 93.30 | 72.90 | 69.35 |
| Tax Annual | 28.94 | 27.56 | 26.57 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 580.55 |
| Operating Expenses Annual | 480.64 |
| Operating Profit Annual | 134.33 |
| Interest Annual | 1.46 |
| Depreciation | 10.52 |
| Net Profit Annual | 93.30 |
| Tax Annual | 28.94 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.58 | 6.57 | 11.03 |
| Cash Flow from Operations | 63.24 | 39.16 | 76.18 |
| Cash Flow from Investing | -57.34 | -36.64 | -78.08 |
| Cash Flow from Financing | -5.18 | -4.50 | -2.56 |
| Cash Flow at the End | 5.31 | 4.58 | 6.57 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 4.58 |
| Cash Flow from Operations | 63.24 |
| Cash Flow from Investing | -57.34 |
| Cash Flow from Financing | -5.18 |
| Cash Flow at the End | 5.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 23.14 | 21.88 | 22.34 |
| PBIT Margin (%) | 21.31 | 20.08 | 20.63 |
| PBT Margin (%) | 6.72 | 10.19 | 6.41 |
| Net PROFIT Margin (%) | 16.07 | 14.29 | 14.69 |
| Return On Networth / Equity (%) | 17.04 | 15.59 | 17.35 |
| Return On Networth /Employed (%) | 22.35 | 21.60 | 24.02 |
| Return On Assets (%) | 16.87 | 15.43 | 17.04 |
| Total Debt / Equity (X) | TBA | TBA | TBA |
| Asset Turnover Ratio (%) | 1.05 | 1.08 | 1.16 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 23.14 |
| PBIT Margin (%) | 21.31 |
| PBT Margin (%) | 6.72 |
| Net PROFIT Margin (%) | 16.07 |
| Return On Networth / Equity (%) | 17.04 |
| Return On Networth /Employed (%) | 22.35 |
| Return On Assets (%) | 16.87 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 1.05 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 179.33 | 150.53 | 131.88 |
| Total Current Assets Annual | 446.55 | 367.00 | 352.56 |
| Non Current Assets Annual | 253.60 | 220.26 | 181.56 |
| Total Shareholders Funds Annual | 592.84 | 502.47 | 432.88 |
| Total Assets Annual | 700.15 | 587.26 | 534.11 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 179.33 |
| Total Current Assets Annual | 446.55 |
| Non Current Assets Annual | 253.60 |
| Total Shareholders Funds Annual | 592.84 |
| Total Assets Annual | 700.15 |
EPS (INR)
Expected
5.78
Reported
5.78
Surprise
0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%
Jun 2024
EPS beaten by 0.00%
